InMode (INMD) Income from Continuing Operations (2018 - 2026)
InMode (INMD) recorded Income from Continuing Operations of $17.06 million in the quarter ended Jun 30, 2026, down 36.2% from $26.74 million a year earlier but up 47.6% from the prior quarter.
InMode (INMD) Income from Continuing Operations (2018 - 2026) Analysis & Trends
On a TTM basis, InMode's Income from Continuing Operations came in at $86.05 million as of Jun 30, 2026, up 10.9% year-over-year; for the year ended Dec 31, 2025, it came in at $126.83 million, up 20.0% from the prior year.
- Annual Income from Continuing Operations has a five-year compound annual growth rate of 11.1% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Income from Continuing Operations came in at $105.66 million in the year ended Dec 31, 2024 (-55.3%), $236.62 million in the year ended Dec 31, 2023 (-2.0%), $241.41 million in the year ended Dec 31, 2022 (+46.2%) and $165.07 million in the year ended Dec 31, 2021 (+120.0%).
- Quarterly Income from Continuing Operations has ranged from -$18.35 million in the quarter ended Dec 31, 2024 to $65.16 million in the quarter ended Dec 31, 2023 over the past five years.
- On a year-over-year basis, Income from Continuing Operations rose in two of the last six quarters, with an average decline of 21.8%.
- Peak year-over-year performance for Income from Continuing Operations in the last five years was growth of 87.2% in the quarter ended Sep 30, 2021, against a decline of 57.3% in the quarter ended Jun 30, 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.56 million (quarter ended Mar 31, 2026), $35.56 million (quarter ended Dec 31, 2025) and $21.86 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 1.76 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 928.00 Mn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 870.00 Mn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 823.20 Mn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 1.48 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | -220.00 Mn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 905.00 Mn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 241.40 Mn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 451.00 Mn |
| 10 | InMode | 897.79 Mn | -728.83 Mn | 71.52 Mn | 17.06 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.06 Mn |
| Mar 31, 2026 | 11.56 Mn |
| Dec 31, 2025 | 35.56 Mn |
| Sep 30, 2025 | 21.86 Mn |
| Jun 30, 2025 | 26.74 Mn |
| Mar 31, 2025 | 18.20 Mn |
| Dec 31, 2024 | -18.35 Mn |
| Sep 30, 2024 | 50.99 Mn |
| Jun 30, 2024 | 23.82 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Dec 31, 2023 | 65.16 Mn |
| Sep 30, 2023 | 46.52 Mn |
| Jun 30, 2023 | 55.73 Mn |
| Mar 31, 2023 | 40.51 Mn |
| Dec 31, 2022 | 37.71 Mn |
| Sep 30, 2022 | 48.79 Mn |
| Jun 30, 2022 | 44.05 Mn |
| Mar 31, 2022 | 30.98 Mn |
| Dec 31, 2021 | 52.69 Mn |
| Sep 30, 2021 | 44.72 Mn |
InMode Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "INMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=INMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();